Vivek Ramaswamy, Director at Arbutus Biopharma, holds 16.07M shares in Arbutus Biopharma (Ticker: ABUS), holds ― shares in Sio Gene Therapies (Ticker: SIOX), holds 51.93M shares in Roivant Sciences (Ticker: ROIV). Most recently, Vivek Ramaswamy Bought ― shares of Arbutus Biopharma on Mar 16, 2015 for an estimated value of ―.